跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
DOVATO 50 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
DOVATO 50 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Viiv Healthcare B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 17, 2022
Approval ID
982d3976c280a42a
Company
Viiv Healthcare B.V.
Type
Standard
Approval Details
Approval Id
982d3976c280a42a
Drug Cima Aemps Name
DOVATO 50 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
191370001IP
Holder Company Name
Viiv Healthcare B.V.
Marketing Company Name
Abacus Medicine A/S
Holder Company Detail Path
/organization/viiv-healthcare-bv
Authorization Date
2022-05-17
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
50 mg/ 300 mg
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Viiv Healthcare B.V.
Company Detail Path
/organization/viiv-healthcare-bv
Company Information
Pharmaceutical Company Name
ViiV Healthcare BV
Country Name
Netherlands
Website
http://viivhealthcare.com/nl-nl
Active Ingredients
DOLUTEGRAVIR SODIO
52.6 mg
LAMIVUDINA
300 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 17, 2022
Approval ID
982d3976c280a42a
Type
Standard
Back to CIMA-AEMPS Approvals
DOVATO 50 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details